Literature DB >> 18521239

Disease incidence and results of extremity lesion treatment: mersey region soft tissue sarcomas (1975-1985).

M J Jane1, P J Hughes.   

Abstract

Purpose. The incidence and treatment results of extremity soft tissue sarcoma (STS) in the Mersey Region, in the absence of a Multi-Disciplinary Unit, for the period 1975-1985, have been analysed.Subjects and methods. Data from cases presenting with STS within the Mersey region, from 1 January 1975 until 31 December 1985, were reviewed. Only patients with sarcoma of head and neck, thoracic wall, abdominal wall, retroperitoneum, limb girdle or extremity were included. Extremity lesions were staged according to the MTS system. Pathological data also were assigned a grade according to tumour differentiation, mitosis count and tumour necrosis. Data from patients with a minimum follow-up of 5 years were collated, and patterns of treatment failure were investigated. Finally, time to first occurrence was analysed.Results and Discussion. The incidence of STS in this study was identical to that reported by the US Department of Health in 1976. Five year survival rate for Stage I tumours was only 51.7% which compares very unfavourably with contemporary series from Multi-Disciplinary Units. Five year survival rate following wide local excision +/- adjuvant therapy is 52.4%, while that following amputation +/- adjuvant therapy is 45.5%. While not attaining the results reported by other centres, limb-sparing surgery does not appear to appreciably prejudice long-term survival.Conclusions. STS are rare in the UK, leading to poor classification and suboptimal treatment of lesions. It is important to establish multidisciplinary teams of surgeons, radiologists, radiotherapists and oncologists to plan and organise multimodality therapy for STS.

Entities:  

Year:  1998        PMID: 18521239      PMCID: PMC2395385          DOI: 10.1080/13577149878046

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  19 in total

1.  Treatment of the patient with stage M0 soft tissue sarcoma.

Authors:  H D Suit; H J Mankin; W C Wood; M C Gebhardt; D C Harmon; A Rosenberg; J E Tepper; D Rosenthal
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

2.  Is there no influence of local control on the rate of metastases in high-grade soft tissue sarcoma?

Authors:  B Rööser; P Gustafson; A Rydholm
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

3.  The management of soft-tissue sarcomas of the extremities.

Authors:  M A Simon; W F Enneking
Journal:  J Bone Joint Surg Am       Date:  1976-04       Impact factor: 5.284

4.  Selective combination of modalities in soft tissue sarcomas: limb salvage and survival.

Authors:  C P Karakousis; L J Emrich; U Rao; M Khalil
Journal:  Semin Surg Oncol       Date:  1988

5.  Surgical management of soft tissue sarcomas, with an analysis of 313 cases.

Authors:  G H Li; J Q Li; Y H Cai; M Huang
Journal:  Semin Surg Oncol       Date:  1988

6.  Surgical treatment of 297 soft tissue sarcomas of the lower extremity.

Authors:  M H Shiu; E B Castro; S I Hajdu; J G Fortner
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

7.  Surgery and postoperative radiotherapy in the treatment of soft tissue sarcomas in adults.

Authors:  R D Lindberg; R G Martin; M M Romsdahl
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-01

8.  Management of soft tissue sarcomas in Portsmouth 1965-1985.

Authors:  V H Svoboda; J Krawczyk
Journal:  Clin Oncol (R Coll Radiol)       Date:  1991-05       Impact factor: 4.126

9.  Surgery for soft tissue sarcoma in the extremities. A multivariate analysis of the 6-26-year prognosis in 137 patients.

Authors:  O Berlin; B Stener; L Angervall; L G Kindblom; G Markhede; A Odén
Journal:  Acta Orthop Scand       Date:  1990-12

Review 10.  Incidence of metastases to lymph nodes from soft-tissue sarcomas.

Authors:  I M Ariel
Journal:  Semin Surg Oncol       Date:  1988
View more
  6 in total

1.  A European project on incidence, treatment, and outcome of sarcoma.

Authors:  Giuseppe Mastrangelo; Emanuela Fadda; Luca Cegolon; Maria C Montesco; Isabel Ray-Coquard; Alessandra Buja; Ugo Fedeli; Alvise Frasson; Paolo Spolaore; Carlo R Rossi
Journal:  BMC Public Health       Date:  2010-04-12       Impact factor: 3.295

2.  Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region.

Authors:  Pierre Etienne Heudel; Philippe Cousin; Antoine Lurkin; Claire Cropet; Françoise Ducimetiere; Olivier Collard; Guy De Laroche; Pierre Biron; Pierre Meeus; Philippe Thiesse; Christophe Bergeron; Gualter Vaz; François Mithieux; Fadila Farsi; Yohan Fayet; François-Noel Gilly; Dominic Cellier; Jean-Yves Blay; Isabelle Ray-Coquard
Journal:  Int J Clin Oncol       Date:  2013-08-10       Impact factor: 3.402

3.  Should Soft Tissue Sarcomas be Treated at a Specialist Centre?

Authors:  A A Bhangu; J A S Beard; R J Grimer
Journal:  Sarcoma       Date:  2004

4.  Is revisional surgery mandatory when an unexpected sarcoma diagnosis is made following primary surgery?

Authors:  Georgios Koulaxouzidis; Eugenia Schwarzkopf; Holger Bannasch; G Björn Stark
Journal:  World J Surg Oncol       Date:  2015-10-24       Impact factor: 2.754

Review 5.  Soft Tissue Sarcomas of the Arm - Oncosurgical and Reconstructive Principles within a Multimodal, Interdisciplinary Setting.

Authors:  Georgios Koulaxouzidis; Filip Simunovic; Holger Bannasch
Journal:  Front Surg       Date:  2016-02-23

6.  Reconstruction of Brachial Artery with Great Saphenous Vein Graft in A Case of Residual Soft Tissue Sarcoma Arm.

Authors:  Sumanjit S Boro; Bibhuti Bhusan Borthakur; Vinay Mamidala
Journal:  World J Plast Surg       Date:  2020-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.